PROTALEX INC
10QSB, EX-27, 2000-10-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PROTALEX INC, 10QSB, 2000-10-13
Next: PNC MORT ACCEPT CORP COMMERC MORT PASS THR CERT SER 1999 CM1, 8-K, 2000-10-13



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              MAY-31-2001
<PERIOD-END>                                   AUG-31-2000
<CASH>                                         343585
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               344085
<PP&E>                                         222021
<DEPRECIATION>                                 21115
<TOTAL-ASSETS>                                 564698
<CURRENT-LIABILITIES>                          91269
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       965891
<OTHER-SE>                                     (742159)
<TOTAL-LIABILITY-AND-EQUITY>                   564698
<SALES>                                        0
<TOTAL-REVENUES>                               3863
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               126785
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             6319
<INCOME-PRETAX>                                (122922)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (122922)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (122922)
<EPS-BASIC>                                    (.01)
<EPS-DILUTED>                                  (.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission